• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利肠球菌对氨苄西林和糖肽类抗生素的耐药性。意大利抗菌药物耐药性监测组

Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.

作者信息

Fontana R, Ligozzi M, Mazzariol A, Veneri G, Cornaglia G

机构信息

Istituto di Microbiologia, Università degli Studi di Verona, Italy.

出版信息

Clin Infect Dis. 1998 Aug;27 Suppl 1:S84-6. doi: 10.1086/514907.

DOI:10.1086/514907
PMID:9710675
Abstract

We report the results of the monitoring of resistance to ampicillin, vancomycin, and teicoplanin in enterococci by an Italian network of clinical microbiology laboratories. A total of 16,226 strains were analyzed; 9,169 of these strains were Enterococcus faecalis, 913 were Enterococcus faecium, and 6,144 were Enterococcus species. The average rate of resistance to ampicillin was 1.9% (range, 0-6.5%) for E. faecalis and 70% (range, 33.3%-98.7%) for E. faecium; the average rate of resistance to vancomycin was 1.1% (range, 0.1%-2%) for E. faecalis and 8.5% (range, 0-36.1%) for E. faecium; and the average rate of resistance to teicoplanin was 0.8% (range, 0-2.4%) for E. faecalis and 8.7% (range, 0-36.1%) for E. faecium.

摘要

我们报告了意大利临床微生物学实验室网络对肠球菌中氨苄西林、万古霉素和替考拉宁耐药性的监测结果。共分析了16226株菌株;其中9169株为粪肠球菌,913株为屎肠球菌,6144株为其他肠球菌属。粪肠球菌对氨苄西林的平均耐药率为1.9%(范围为0 - 6.5%),屎肠球菌为70%(范围为33.3% - 98.7%);粪肠球菌对万古霉素的平均耐药率为1.1%(范围为0.1% - 2%),屎肠球菌为8.5%(范围为0 - 36.1%);粪肠球菌对替考拉宁的平均耐药率为0.8%(范围为0 - 2.4%),屎肠球菌为8.7%(范围为0 - 36.1%)。

相似文献

1
Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.意大利肠球菌对氨苄西林和糖肽类抗生素的耐药性。意大利抗菌药物耐药性监测组
Clin Infect Dis. 1998 Aug;27 Suppl 1:S84-6. doi: 10.1086/514907.
2
Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.来自九个欧盟国家(EASSA 研究)健康牛、猪和鸡中肠球菌对抗菌药物的药敏性。
Vet Microbiol. 2018 Mar;216:168-175. doi: 10.1016/j.vetmic.2018.02.010. Epub 2018 Feb 10.
3
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.多重耐药革兰氏阳性病原体。当前微生物学模式的最新情况。
Drugs. 1997;54 Suppl 6:11-20. doi: 10.2165/00003495-199700546-00005.
4
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].[从尿液中分离出的肠球菌属的抗生素敏感性分析]
Przegl Lek. 2004;61(5):473-6.
5
Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.万古霉素耐药肠球菌的发生与糖肽类抗生素使用的关系。
Acta Univ Palacki Olomuc Fac Med. 1999;142:69-71.
6
The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.新型糖肽类药物LY333328对耐万古霉素肠球菌临床分离株的体外活性
Adv Exp Med Biol. 1997;418:483-5. doi: 10.1007/978-1-4899-1825-3_115.
7
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.意大利临床实验室运用常规实验室方法检测肠球菌和葡萄球菌属中糖肽敏感性降低情况的能力。
Clin Microbiol Infect. 2002 Feb;8(2):101-11. doi: 10.1046/j.1469-0691.2002.00378.x.
8
Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.中国多家医疗机构住院患者分离的万古霉素耐药肠球菌属临床分离株的分子特征。
Diagn Microbiol Infect Dis. 2012 Dec;74(4):399-403. doi: 10.1016/j.diagmicrobio.2012.09.006. Epub 2012 Oct 23.
9
Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.一种新型糖肽类抗生素(LY333328)对肠球菌及其他耐药革兰氏阳性菌的活性。
J Antimicrob Chemother. 1997 Sep;40(3):423-5. doi: 10.1093/jac/40.3.423.
10
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.克林沙星与其他抗菌药物对万古霉素敏感和耐药肠球菌的体外比较活性。
Chemotherapy. 1996 Jul-Aug;42(4):235-9. doi: 10.1159/000239449.

引用本文的文献

1
Prevalence of vancomycin-resistant Enterococcus in Iran: a systematic review and meta-analysis.伊朗耐万古霉素肠球菌的患病率:一项系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1387-92. doi: 10.1007/s10096-016-2702-0. Epub 2016 Jun 25.
2
Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011.2004 年至 2011 年间,意大利参与替加环素评估和监测试验所收集的革兰氏阴性和革兰氏阳性菌的抗菌药物敏感性纵向评估。
Pharmaceuticals (Basel). 2013 Nov 7;6(11):1381-406. doi: 10.3390/ph6111381.
3
Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy.
一株耐万古霉素屎肠球菌在意大利血流感染分离株中的克隆传播。
J Clin Microbiol. 2005 Apr;43(4):1575-80. doi: 10.1128/JCM.43.4.1575-1580.2005.
4
Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.评估VITEK 2系统用于医学相关革兰氏阳性球菌的鉴定和抗菌药敏试验。
J Clin Microbiol. 2002 May;40(5):1681-6. doi: 10.1128/JCM.40.5.1681-1686.2002.
5
Routine molecular identification of enterococci by gene-specific PCR and 16S ribosomal DNA sequencing.通过基因特异性聚合酶链反应和16S核糖体DNA测序对肠球菌进行常规分子鉴定。
J Clin Microbiol. 2001 Feb;39(2):794-7. doi: 10.1128/JCM.39.2.794-797.2001.